Zuriphen SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100mg, Paracetamol 325mg, and Serratiopeptidase 15mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol, a widely used analgesic and antipyretic agent, provides effective pain relief and fever reduction through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of inflammation and edema, enhancing tissue healing. This synergistic combination is indicated for the management of acute and chronic musculoskeletal pain, rheumatoid arthritis, osteoarthritis, postoperative inflammation, and soft tissue injuries. Zuriphen SP Tablet offers rapid pain relief, reduction of inflammation, and improved functional mobility. It is generally well-tolerated; however, caution is advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to any component. The medication should be used under medical supervision, adhering to recommended dosages to minimize adverse effects such as gastrointestinal discomfort, allergic reactions, or hepatic dysfunction. Zuriphen SP Tablet represents an effective therapeutic option for comprehensive pain and inflammation management.